# Texas Medical Center Training Program in Antimicrobial Resistance

> **NIH NIH T32** · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · 2022 · $311,845

## Abstract

PROJECT SUMMARY/ABSTRACT
The rise of antibiotic-resistant microorganisms globally has become a critical public health priority due to the
devastating consequences that it may have to the world health and economy. Indeed, antibiotic resistance
threatens the progress of medicine in all areas and, as such, the issue has reached the highest level of
government, including the Office of the US President (with the creation of the Presidential Advisory Council on
Combating Antibiotic-Resistant Bacteria) and the initiative for global action by the United Nations, among
others. Houston is the home to the largest cluster of healthcare institutions in the world, the Texas Medical
Center (TMC) with more than 9,200 hospital beds, receiving more than 8 million patient visits per year.
Additionally, the Houston area harbors a strong history of outstanding infectious diseases research and training
including that focused on antimicrobial resistance (AMR) and antibiotic stewardship. In the last two years, the
formation of the UTHealth Center for Antimicrobial Resistance and Microbial Genomics (CARMiG) and the
Gulf Coast Consortia (GCC) Cluster for Antimicrobial Resistance (GCC-AMR) has resulted in an active,
multidisciplinary and comprehensive research and educational program that has amalgamated the efforts of
AMR researchers and created the resources, personnel, funding and fertile ground to launch an ambitious,
innovative and unparalleled training program on AMR. We propose to establish the Texas Medical Center
Training Program on AMR (TPAMR) that seeks to train postdoctoral scholars, clinical residents and fellows
from seven geographically adjacent institutions in the TMC (University of Texas Health Science Center at
Houston, MD Anderson Cancer Center, Baylor College of Medicine, University of Texas Medical Branch, Rice
University, University of Houston, and Institute of Biosciences and Technology of Texas A&M University) on
advanced aspects of AMR research. We aim to take advantage of the strong expertise of the GCC on
successful T32 programs in other areas and the educational activities already in place at CARMiG, combined
with the expertise of world-class researchers on AMR in the TMC. TPAMR seeks to leverage all the available
resources to train the next generation of scientists and clinician-scientists (MDs, PhDs and PharmDs) focused
on tackling the pressing AMR public health crisis. The highly collaborative environment provides the perfect
opportunity for trainees to acquire the skills, expertise and intellectual abilities to foster innovative research that
has a strong translational component and could be developed to directly influence patient care. The focus of
expertise of the proposed training grant includes, i) molecular basis of antibiotic resistance, ii) bacterial
genomics and bioinformatics, iii) microbiome science, iv) pharmacological aspects of resistance, v) clinical
epidemiology and biostatistics of AMR and, vi) antibiotic stewardship. We beli...

## Key facts

- **NIH application ID:** 10401444
- **Project number:** 5T32AI141349-04
- **Recipient organization:** UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
- **Principal Investigator:** Anthony Richard Flores
- **Activity code:** T32 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $311,845
- **Award type:** 5
- **Project period:** 2019-07-01 → 2024-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10401444

## Citation

> US National Institutes of Health, RePORTER application 10401444, Texas Medical Center Training Program in Antimicrobial Resistance (5T32AI141349-04). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10401444. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*